Organogenesis Holdings Inc. (ORGO)

USD 4.33

(1.64%)

Operating Income Summary of Organogenesis Holdings Inc.

  • Organogenesis Holdings Inc.'s latest annual operating income in 2023 was 12.52 Million USD , down -26.82% from previous year.
  • Organogenesis Holdings Inc.'s latest quarterly operating income in 2024 Q2 was 8.9 Million USD , down -260.64% from previous quarter.
  • Organogenesis Holdings Inc. reported an annual operating income of 22.3 Million USD in 2022, down -69.41% from previous year.
  • Organogenesis Holdings Inc. reported an annual operating income of 72.91 Million USD in 2021, up 165.98% from previous year.
  • Organogenesis Holdings Inc. reported a quarterly operating income of -3.85 Million USD for 2024 Q1, down -693.53% from previous quarter.
  • Organogenesis Holdings Inc. reported a quarterly operating income of -3.97 Million USD for 2023 Q1, down -195.56% from previous quarter.

Annual Operating Income Chart of Organogenesis Holdings Inc. (2023 - 2016)

Historical Annual Operating Income of Organogenesis Holdings Inc. (2023 - 2016)

Year Operating Income Operating Income Growth
2023 12.52 Million USD -26.82%
2022 22.3 Million USD -69.41%
2021 72.91 Million USD 165.98%
2020 27.41 Million USD 193.06%
2019 -29.45 Million USD 42.86%
2018 -51.55 Million USD -1022.78%
2017 -4.59 Million USD -2300.23%
2016 208.69 Thousand USD 0.0%

Peer Operating Income Comparison of Organogenesis Holdings Inc.

Name Operating Income Operating Income Difference
Collegium Pharmaceutical, Inc. 166.96 Million USD 92.498%
Embecta Corp. 221.5 Million USD 94.345%
ANI Pharmaceuticals, Inc. 46.97 Million USD 73.335%
Dynavax Technologies Corporation -37.02 Million USD 133.826%
Esperion Therapeutics, Inc. -155.56 Million USD 108.051%
Pacira BioSciences, Inc. 87.67 Million USD 85.714%
PainReform Ltd. -9.58 Million USD 230.687%
Aquestive Therapeutics, Inc. -15.1 Million USD 182.936%
Sunshine Biopharma, Inc. -4.78 Million USD 361.739%
SCYNEXIS, Inc. 72.66 Million USD 82.764%
China SXT Pharmaceuticals, Inc. -2.51 Million USD 597.969%
Cosmos Health Inc. -21.83 Million USD 157.372%
Journey Medical Corporation -2.07 Million USD 704.197%
Sunshine Biopharma, Inc. -4.78 Million USD 361.739%
Safety Shot Inc -12.18 Million USD 202.797%
Alpha Teknova, Inc. -35.56 Million USD 135.219%
Intra-Cellular Therapies, Inc. -159.38 Million USD 107.859%
Bright Green Corporation -8.89 Million USD 240.867%
Procaps Group, S.A. 38.97 Million USD 67.862%
Theratechnologies Inc. -10.62 Million USD 217.86%
Harrow Health, Inc. 580 Thousand USD -2059.483%
Sonoma Pharmaceuticals, Inc. -4.7 Million USD 366.433%
Biofrontera Inc. -22.67 Million USD 155.232%
DURECT Corporation -36.88 Million USD 133.958%
Supernus Pharmaceuticals, Inc. -5.26 Million USD 337.711%
Cronos Group Inc. -81.37 Million USD 115.392%
OptiNose, Inc. -22.74 Million USD 155.06%
Ironwood Pharmaceuticals, Inc. 209.03 Million USD 94.008%
Kala Pharmaceuticals, Inc. -39.15 Million USD 131.99%
RedHill Biopharma Ltd. 12.63 Million USD 0.847%
Guardion Health Sciences, Inc. -4.33 Million USD 388.84%
Cumberland Pharmaceuticals Inc. -6.21 Million USD 301.664%
Radius Health, Inc. -3.92 Million USD 419.108%
Universe Pharmaceuticals INC -3.52 Million USD 455.14%
ProPhase Labs, Inc. -21.61 Million USD 157.951%
Phibro Animal Health Corporation 53.31 Million USD 76.508%
Procaps Group S.A. 52.32 Million USD 76.063%
Alvotech -354.86 Million USD 103.53%
TherapeuticsMD, Inc. -8.52 Million USD 246.955%
Viatris Inc. 766.2 Million USD 98.365%
Rockwell Medical, Inc. -6.67 Million USD 287.781%
Aytu BioPharma, Inc. -5.25 Million USD 338.39%
SIGA Technologies, Inc. 83.62 Million USD 85.022%
Tilray Brands, Inc. -174.74 Million USD 107.168%
Lifecore Biomedical, Inc. 9.33 Million USD -34.23%
Shineco, Inc. -17.06 Million USD 173.392%
PetIQ, Inc. 60.01 Million USD 79.13%
Regencell Bioscience Holdings Limited -4.73 Million USD 364.423%
Incannex Healthcare Limited -30.04 Million USD 141.693%
Neurocrine Biosciences, Inc. 250.9 Million USD 95.008%
Alimera Sciences, Inc. -1.47 Million USD 951.462%
Silver Spike Investment Corp. 7.34 Million USD -70.638%
Assertio Holdings, Inc. -243.53 Million USD 105.143%
Shuttle Pharmaceuticals Holdings, Inc. -5.89 Million USD 312.563%
Petros Pharmaceuticals, Inc. -13.61 Million USD 191.978%
Clever Leaves Holdings Inc. -15.59 Million USD 180.319%
Cyclo Therapeutics, Inc. -20.05 Million USD 162.469%
Avadel Pharmaceuticals plc -137.84 Million USD 109.086%
Hempacco Co., Inc. -8.81 Million USD 242.131%
Talphera, Inc. -16.88 Million USD 174.161%
Alvotech -354.86 Million USD 103.53%
Eagle Pharmaceuticals, Inc. 53.45 Million USD 76.569%
Lantheus Holdings, Inc. 364.64 Million USD 96.565%
Currenc Group, Inc. -6.64 Million USD 288.465%
Kamada Ltd. 10.06 Million USD -24.453%
Indivior PLC -4 Million USD 413.125%
Evoke Pharma, Inc. -7.43 Million USD 268.553%
Flora Growth Corp. -50.35 Million USD 124.874%
Cyclo Therapeutics, Inc. -20.05 Million USD 162.469%
Evolus, Inc. -49.23 Million USD 125.44%
HUTCHMED (China) Limited 18.37 Million USD 31.837%
Amphastar Pharmaceuticals, Inc. 196.98 Million USD 93.642%
Akanda Corp. -10.05 Million USD 224.61%